Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials
    Published on 2024-12-29
    1 year ago
  • Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study
    Published on 2024-12-23
    1 year ago
  • Epac2-mediated synaptic insertion of Ca2+-permeable AMPARs in the nucleus accumbens contributes to incubation of cocaine craving
    Published on 2024-12-18
    1 year ago
  • Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
    Published on 2024-12-18
    1 year ago
  • Neural basis of adolescent THC-induced potentiation of opioid responses later in life
    Published on 2024-12-09
    1 year ago
  • Correction: The might of light for revealing neuropsychiatric mechanisms
    Published on 2024-12-08
    1 year ago
  • The efficacy and cerebral mechanism of intradermal acupuncture for major depressive disorder: a multicenter randomized controlled trial
    Published on 2024-12-07
    1 year ago
« Previous 1 … 57 58 59 60 61 … 143 Next »
Journal of Psychopharmacology
  • Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice
    Published on 2023-07-03
    3 years ago
  • Psilocybin’s effects on cognition and creativity: A scoping review
    Published on 2023-07-03
    3 years ago
  • Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
    Published on 2023-07-01
    3 years ago
  • Harnessing placebo: Lessons from psychedelic science
    Published on 2023-07-01
    3 years ago
  • Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia
    Published on 2023-06-28
    3 years ago
  • The New Zealand drug harms ranking study: A multi-criteria decision analysis
    Published on 2023-06-24
    3 years ago
  • Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion
    Published on 2023-06-19
    3 years ago
« Previous 1 … 57 58 59 60 61 … 145 Next »
European Neuropsychopharmacology
  • Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
    Published on 2023-08-08
    3 years ago
  • Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia
    Published on 2023-08-07
    3 years ago
  • Neutrophil to lymphocyte ratio and antidepressant treatment response in patients with major depressive disorder: Effect of sex and hippocampal volume
    Published on 2023-08-05
    3 years ago
  • The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials
    Published on 2023-08-05
    3 years ago
  • The Mechanism of Akathisia – Comments on Wu et al. Eur Neuropsychopharmacol 2023;72:40–49
    Published on 2023-07-26
    3 years ago
  • Measuring serum concentrations of psychotropics- Valuable tool for decision making or waste of money?
    Published on 2023-07-21
    3 years ago
  • A new approach to negative symptoms of schizophrenia
    Published on 2023-07-15
    3 years ago
« Previous 1 … 57 58 59 60 61 … 166 Next »

   Pharma Pub